# A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)

> **NCT01350934** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 219 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **DRUG:** alendronate 70-mg/vitamin D3 5600 IU combination tablet (Fosamax Plus)
- **DRUG:** Calcitriol
- **DIETARY_SUPPLEMENT:** Calcium 500 mg

## Key facts

- **NCT ID:** NCT01350934
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-19
- **Primary completion:** 2013-01-10
- **Final completion:** 2013-01-10
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01350934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01350934, "A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01350934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*